DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Ortataxel
Ortataxel
Solid Forms of Ortataxel Feste Formen Von Ortataxel Formes Solides D’Ortataxel
SPECTRUM PHARMACEUTICALS, INC. (Exact Name of Registrant As Specified in Its Charter)
Multicenter, Single Arm, Phase II Trial on the Efficacy of Ortataxel in Recurrent Glioblastoma (2019) Journal of Neuro-Oncology, 142 (3), Pp
Tanibirumab (CUI C3490677) Add to Cart
WO 2015/042414 Al 26 March 2015 (26.03.2015) P O P C T
Modifications to the Harmonized Tariff Schedule of the United States To
(12) United States Patent (10) Patent No.: US 8,911,786 B2 Desai Et Al
I Regulations
REVIEW Taxanes: Promising Anti-Cancer Drugs
(12) United States Patent (10) Patent No.: US 8,158,152 B2 Palepu (45) Date of Patent: Apr
(12) United States Patent (10) Patent No.: US 8,835,443 B2 Kawasaki Et Al
Ep 3067054 A1
Genetic Toxicity Mini-Adverse Outcome Pathways (Mini-Aops)
Stembook 2018.Pdf
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
(12) United States Patent (10) Patent No.: US 8,512,679 B2 Hyde Et Al
79. Mitosis Inhibitors Mitosis Is the Process in Which a Eukaryotic Cell Separates the Chromosomes in Its Cell Nucleus Into Two Identical Sets in Two Daughter Nuclei
United States Patent (10) Patent No.: US 9,605,003 B2 Castro Et Al
Top View
( 12 ) United States Patent
Natural Products As Lead Compounds in Drug Discovery
Microtubule-Binding Agents: a Dynamic Field of Cancer Therapeutics. Charles Dumontet, Mary Ann Jordan
WO 2010/091198 Al
Anticancer Potential of Betulonic Acid Derivatives
Ready for a Comeback of Natural Products in Oncology Christian Bailly
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Customs Tariff - Schedule
Non-Commercial Use Only
(12) Patent Application Publication (10) Pub. No.: US 2010/0331307 A1 Salituro Et Al
Structure-Activity Analysis of Taxane-Based Broad-Spectrum Multidrug Resistance Modulators
Pharmaabkommen A1 E
Pharmacokinetic Optimization of Docetaxel Dosing Frederike Engels
Customs Tariff - Schedule Xxi - 1
2008 Annual Report
Novel Oral Taxane Therapies: Recent Phase I Results
Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 1352 Drug Compounds
Drug Design: Hiding in Full View à Norman S